{"DataElement":{"publicId":"7292189","version":"1","preferredName":"Acute Lymphoblastic Leukemia Classification ALL Type","preferredDefinition":"A description of the acute lymphoblastic leukemia classification type.","longName":"ALL_CLASS_ALL_TYPE","context":"DCI","contextVersion":"1","DataElementConcept":{"publicId":"2674125","version":"2","preferredName":"Acute Lymphoblastic Leukemia Classification","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood.  It includes the precursor B lymphoblastic leukemia and precursor T lymphoblastic leukemia._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"ALL_CLASS","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2674126","version":"1","preferredName":"ALL","preferredDefinition":"A leukemia with an acute onset, characterized by the presence of lymphoblasts or Burkitt cells in the bone marrow and the peripheral blood.  It includes the precursor B lymphoblastic leukemia, precursor T lymphoblastic leukemia, and Burkitt's leukemia.","longName":"C3167","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3834F55C-324A-1EBE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-21","modifiedBy":"ONEDATA","dateModified":"2007-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2F9B8C8-5FD9-D64C-E040-BB89AD432D31","latestVersionIndicator":"Yes","beginDate":"2013-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7292149","version":"1","preferredName":"ALL Classification Type","preferredDefinition":"A leukemia with an acute onset, characterized by the presence of lymphoblasts or Burkitt cells in the bone marrow and the peripheral blood.  It includes the precursor B lymphoblastic leukemia, precursor T lymphoblastic leukemia, and Burkitt's leukemia._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics._Something distinguishable as an identifiable class based on common qualities.","longName":"ALL_CLASS_TYPE","context":"DCI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"B-lymphoblastic leukemia / lymphoma with Hyperdiploidy (the leukemia cells have more than 50 chromosomes)","valueDescription":"B Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy","ValueMeaning":{"publicId":"5574403","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy","longName":"5574403","preferredDefinition":"A precursor lymphoid neoplasm composed of B-lymphoblasts which contain more than 50 and usually less than 66 chromosomes. It has a favorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperdiploid B Lymphoblastic Leukemia/Lymphoma","conceptCode":"C80335","definition":"A precursor lymphoid neoplasm composed of B-lymphoblasts which contain more than 50 and usually less than 66 chromosomes. It has a favorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41457D3D-76BA-5F06-E053-F662850A638F","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-14","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58B27B9-5302-7856-E053-F662850A4E70","beginDate":"2013-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma with recurrent genetic abnormalities","valueDescription":"B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities","ValueMeaning":{"publicId":"7283806","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities","longName":"7283806","preferredDefinition":"The term refers to precursor lymphoid neoplasms which are composed of B-lymphoblasts and characterized by the presence of recurrent genetic abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities","conceptCode":"C80328","definition":"B-lymphoblastic leukemias/lymphomas characterized by the presence of recurring cytogenetic and/or molecular abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5023689-8498-2F85-E053-F662850A65C9","latestVersionIndicator":"Yes","beginDate":"2020-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-07","modifiedBy":"ONEDATA","dateModified":"2020-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AD989-9DC0-01C2-E053-F662850A3C21","beginDate":"2020-05-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma with t(12;21) (p13.2;q22.1); ETV6-RUNX1","valueDescription":"B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1","ValueMeaning":{"publicId":"5574407","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1","longName":"5574407","preferredDefinition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. It has a favorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1","conceptCode":"C80334","definition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. It has a favorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41457D3D-7706-5F06-E053-F662850A638F","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Updated definition and VM Long Name_ghd_11.16.16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AD989-9DCA-01C2-E053-F662850A3C21","beginDate":"2007-08-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1","valueDescription":"B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)","ValueMeaning":{"publicId":"5589065","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)","longName":"5589065","preferredDefinition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1","conceptCode":"C80341","definition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42B3B596-6A5E-73CB-E053-F662850A292D","latestVersionIndicator":"Yes","beginDate":"2016-12-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AD989-9DD4-01C2-E053-F662850A3C21","beginDate":"2007-08-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma with t(5;14) (q31.1;q32.3); IL3-IGH","valueDescription":"B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH","ValueMeaning":{"publicId":"3935832","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH","longName":"3935832","preferredDefinition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, (q31.1;q32.3). It results in eosinophilia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH","conceptCode":"C80340","definition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the IL3 gene on chromosome 5 and the IGH locus on chromosome 14, (q31.1;q32.3). It results in eosinophilia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9E0CCBC-2953-32FB-E040-BB89AD43176B","latestVersionIndicator":"Yes","beginDate":"2013-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-29","modifiedBy":"KUMMEROA","dateModified":"2022-11-28","changeDescription":"Updated definition and VM Long Name_ghd_11.16.16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AD989-9DDE-01C2-E053-F662850A3C21","beginDate":"2013-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1","valueDescription":"B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1","ValueMeaning":{"publicId":"5574409","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1","longName":"5574409","preferredDefinition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1","conceptCode":"C80331","definition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41457D3D-7740-5F06-E053-F662850A638F","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Updated VM Long Name_ghd_11.16.16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AD989-9DE8-01C2-E053-F662850A3C21","beginDate":"2007-08-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma with t(v;11q23.3); KMT2A rearranged","valueDescription":"B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged","ValueMeaning":{"publicId":"5574411","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged","longName":"5574411","preferredDefinition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the KMT2A gene at 11q23.3 and another gene partner resulting in the production of a KMT2A related fusion protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged","conceptCode":"C80332","definition":"A precursor lymphoid neoplasm which is composed of B-lymphoblasts and carries a translocation between the KMT2A gene at 11q23.3 and another gene partner resulting in the production of an KMT2A related fusion protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41457D3D-7766-5F06-E053-F662850A638F","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Updated definition and VM Long Name_ghd_11.16.16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AD989-9DF2-01C2-E053-F662850A3C21","beginDate":"2007-08-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma, with iAMP21","valueDescription":"Intrachromosomal Amplification of Chromosome 21 B Lymphoblastic Leukemia/Lymphoma","ValueMeaning":{"publicId":"5574521","version":"1","preferredName":"Intrachromosomal Amplification of Chromosome 21 B Lymphoblastic Leukemia/Lymphoma","longName":"5574521","preferredDefinition":"A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.: A neoplasm of lymphoblasts committed to the B-cell lineage, typically composed of small to medium-sized blast cells.  When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is called B acute lymphoblastic leukemia.  When it involves nodal or extranodal sites, it is called B lymphoblastic lymphoma. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrachromosomal Amplification of Chromosome 21","conceptCode":"C124874","definition":"A cytogenetic abnormality that refers to the allelic gain of an internal part of chromosome 21. It is a rare high-risk chromosomal abnormality that occurs in approximately 2-5% of pediatric patients with B-cell precursor Acute Lymphoblastic Leukemia. This abnormality has been associated with a poor outcome in patients treated by standard protocols.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"B Lymphoblastic Leukemia/Lymphoma","conceptCode":"C8936","definition":"A neoplasm of lymphoblasts committed to the B-cell lineage, typically composed of small to medium-sized blast cells.  When the neoplasm involves predominantly the bone marrow and the peripheral blood, it is called B acute lymphoblastic leukemia.  When it involves nodal or extranodal sites, it is called B lymphoblastic lymphoma. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41473745-4548-3570-E053-F662850A84CC","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AD989-9E1A-01C2-E053-F662850A3C21","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"Early T-cell precursor lymphoblastic leukemia","valueDescription":"Early T Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"6590924","version":"1","preferredName":"Early T Acute Lymphoblastic Leukemia","longName":"6590924","preferredDefinition":"T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Early T Precursor Acute Lymphoblastic Leukemia","conceptCode":"C130043","definition":"T acute lymphoblastic leukemia in which the blasts have unique immunophenotypic and genetic characteristics suggesting only limited early T-cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7CFDBBAF-474E-5364-E053-F662850ABA26","latestVersionIndicator":"Yes","beginDate":"2018-12-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-12-14","modifiedBy":"ONEDATA","dateModified":"2018-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AD989-9E24-01C2-E053-F662850A3C21","beginDate":"2019-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma, BCR-ABL1-like","valueDescription":"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like","ValueMeaning":{"publicId":"5578251","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like","longName":"5578251","preferredDefinition":"B lymphoblastic leukemia/lymphoma with translocations involving tyrosine kinases, or translocations involving either the cytokine receptor-like factor 2 (CRLF2) or rearrangements leading to truncation and activation of the erythropoietin receptor (EPOR). It is associated with an adverse prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like","conceptCode":"C129787","definition":"B lymphoblastic leukemia/lymphoma characterized by a gene-expression profile similar to that of BCR-ABL1-positive B lymphoblastic leukemia/lymphoma, absence of the pathognomonic BCR-ABL1 rearrangement, alterations of lymphoid transcription factor genes, and a poor outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41817DF1-B35B-6EFE-E053-F662850A0613","latestVersionIndicator":"Yes","beginDate":"2016-11-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AC820-E0DB-1598-E053-F662850AC34F","beginDate":"2016-11-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma, NOS","valueDescription":"B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified","ValueMeaning":{"publicId":"5574401","version":"1","preferredName":"Blastic Plasmacytoid Dendritic Cell Neoplasm","longName":"5574401v1.00","preferredDefinition":"A clinically aggressive neoplasm derived from the precursors of plasmacytoid dendritic cells (also called professional type I interferon-producing cells or plasmacytoid monocytes), with a high frequency of cutaneous and bone marrow involvement and leukemic dissemination. (WHO 2017)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blastic Plasmacytoid Dendritic Cell Neoplasm","conceptCode":"C7203","definition":"A clinically aggressive neoplasm derived from the precursors of plasmacytoid dendritic cells (also called professional type I interferon-producing cells or plasmacytoid monocytes), with a high frequency of cutaneous and bone marrow involvement and leukemic dissemination. (WHO 2017)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41457D3D-7694-5F06-E053-F662850A638F","latestVersionIndicator":"Yes","beginDate":"2016-11-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-14","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58AC820-E0EF-1598-E053-F662850AC34F","beginDate":"2007-08-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"MPAL, T / myeloid, NOS","valueDescription":"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified","ValueMeaning":{"publicId":"4538437","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified","longName":"4538437","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for MLL translocation and t(9;22)(q34;q11.2) translocation.  The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, T/Myeloid","conceptCode":"C82213","definition":"A rare mixed phenotype acute leukemia in which the blasts express T-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"058F579C-8D6D-3DA1-E050-BB89AD436D0B","latestVersionIndicator":"Yes","beginDate":"2014-10-16","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-16","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58A114D-C386-7F5E-E053-F662850ABEC8","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"MPAL, B / myeloid, NOS","valueDescription":"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified","ValueMeaning":{"publicId":"4538435","version":"1","preferredName":"Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified","longName":"4538435","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for MLL translocation and t(9;22)(q34;q11.2) translocation.  The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia, B/Myeloid","conceptCode":"C82212","definition":"A rare mixed phenotype acute leukemia in which the blasts express B-lymphoid and myeloid lineage markers but are negative for KMT2A rearrangement and t(9;22)(q34;q11.2) translocation. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"058F579C-8D47-3DA1-E050-BB89AD436D0B","latestVersionIndicator":"Yes","beginDate":"2014-10-16","endDate":null,"createdBy":"WONGW","dateCreated":"2014-10-16","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58A114D-C39A-7F5E-E053-F662850ABEC8","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"MPAL with t(v;11q23.3); KMT2A rearranged","valueDescription":"Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged","ValueMeaning":{"publicId":"5577812","version":"1","preferredName":"Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged","longName":"5577812","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts also carry a translocation (v; 11q23.3) involving the KMT2A gene. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia with KMT2A Rearrangement","conceptCode":"C82203","definition":"A rare mixed phenotype acute leukemia in which the blasts carry a translocation between the KMT2A gene at 11q23.3 and another gene partner. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"416EFFB6-E475-65FA-E053-F662850A1146","latestVersionIndicator":"Yes","beginDate":"2016-11-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-16","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":"Update definition and VM Long Name_ghd_11.16.16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58A114D-C3AE-7F5E-E053-F662850ABEC8","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"Mixed phenotype acute leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1","valueDescription":"Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1","ValueMeaning":{"publicId":"5577814","version":"1","preferredName":"Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1","longName":"5577814","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts also carry the translocation t(9;22)(q34.1;q11.2) by karyotypic analysis or the BCR-ABL1 translocation by FISH or PCR.  The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion","conceptCode":"C82192","definition":"A rare mixed phenotype acute leukemia in which the blasts carry the chromosomal translocation t(9;22)(q34.1;q11.2) that results in BCR-ABL1 gene fusion. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"416EFFB6-E49B-65FA-E053-F662850A1146","latestVersionIndicator":"Yes","beginDate":"2016-11-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-16","modifiedBy":"COOPERM","dateModified":"2018-12-17","changeDescription":"Updated definition and VM Long Name_ghd_11.16.16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58A114D-C3B8-7F5E-E053-F662850ABEC8","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"Acute undifferentiated leukemia","valueDescription":"Acute Undifferentiated Leukemia","ValueMeaning":{"publicId":"3322385","version":"1","preferredName":"Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion","longName":"3322385v1.00","preferredDefinition":"A rare mixed phenotype acute leukemia in which the blasts carry the chromosomal translocation t(9;22)(q34.1;q11.2) that results in BCR-ABL1 gene fusion. The prognosis is usually unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion","conceptCode":"C82192","definition":"A rare mixed phenotype acute leukemia in which the blasts carry the chromosomal translocation t(9;22)(q34.1;q11.2) that results in BCR-ABL1 gene fusion. The prognosis is usually unfavorable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BB97-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"KUMMEROA","dateModified":"2024-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58A114D-C3C2-7F5E-E053-F662850ABEC8","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia / lymphoma with hypodiploidy (the leukemia cells have fewer than 44 chromosomes [normal cells have 46])","valueDescription":"Hypodiploid B Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"4787216","version":"1","preferredName":"Hypodiploid B Acute Lymphoblastic Leukemia","longName":"4787216","preferredDefinition":"A B-cell acute leukemia characterized by the presence of lymphoblasts which contain less than 46 chromosomes. It occurs in both children and adults. It has an unfavorable clinical outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypodiploid B Acute Lymphoblastic Leukemia","conceptCode":"C80345","definition":"A B-cell acute leukemia characterized by the presence of lymphoblasts which contain less than 46 chromosomes. It occurs in both children and adults. It has an unfavorable clinical outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13512EE0-BEA7-F3CD-E050-BB89AD432E2B","latestVersionIndicator":"Yes","beginDate":"2015-04-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-04-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A58A114D-C3D6-7F5E-E053-F662850ABEC8","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7292148","version":"1","preferredName":"Acute Lymphoblastic Leukemia Classification Type","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.:Something distinguishable as an identifiable class based on common qualities.","longName":"C3167:C25161:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58AD989-9D91-01C2-E053-F662850A3C21","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"ONEDATA","dateModified":"2020-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58AD989-9DA2-01C2-E053-F662850A3C21","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Classification of Acute lymph","type":"Preferred Question Text","description":"Classification of Acute lymphoblastic leukemia","url":null,"context":"DCI"}],"origin":"DCI CRF:  Duke Cancer Institute Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58AD989-9E44-01C2-E053-F662850A3C21","latestVersionIndicator":"Yes","beginDate":"2020-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-05-13","modifiedBy":"KUMMEROA","dateModified":"2020-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}